Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Edler

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|March 10, 2004
Effect of thiol antioxidant on body fat and insulin reactivityWulf Hildebrandt, Andreas Hamann, Holger Krakowski-Roosen, et al.
Magnetic Resonance in Medicine|April 8, 2006
Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in miceBram Stieltjes, Stefan Klussmann, Michael Bock, et al.
International Journal of Cancer|December 25, 2008
Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patientsPhillip J Müller, Heike Dally, Cornelia N Klappenecker, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, et al.
Anticancer Research|August 17, 2005
Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lungKatharina Blonski, Udo Schumacher, Iris Burkholder, et al.
Nature Medicine|March 9, 2004
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injuryDeana Demjen, Stefan Klussmann, Susanne Kleber, et al.
BMC Cancer|October 4, 2011
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancerChristoph Reissfelder, Carmen Timke, Hubertus Schmitz-Winnenthal, et al.
Breast Cancer Research and Treatment|April 26, 2017
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, et al.
Breast Cancer Research and Treatment|April 11, 2009
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphismsAnna Jakubowska, Jacek Gronwald, Janusz Menkiszak, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI TrialGregor Habl, Matthias Uhl, Sonja Katayama, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of Molecular Medicine (Berlin, Germany)|March 10, 2004
Effect of thiol antioxidant on body fat and insulin reactivityWulf Hildebrandt, Andreas Hamann, Holger Krakowski-Roosen, et al.
Magnetic Resonance in Medicine|April 8, 2006
Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in miceBram Stieltjes, Stefan Klussmann, Michael Bock, et al.
International Journal of Cancer|December 25, 2008
Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patientsPhillip J Müller, Heike Dally, Cornelia N Klappenecker, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, et al.
Anticancer Research|August 17, 2005
Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lungKatharina Blonski, Udo Schumacher, Iris Burkholder, et al.
Nature Medicine|March 9, 2004
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injuryDeana Demjen, Stefan Klussmann, Susanne Kleber, et al.
BMC Cancer|October 4, 2011
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancerChristoph Reissfelder, Carmen Timke, Hubertus Schmitz-Winnenthal, et al.
Breast Cancer Research and Treatment|April 26, 2017
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)Cornelia von Hagens, Ingeborg Walter-Sack, Maren Goeckenjan, et al.
Breast Cancer Research and Treatment|April 11, 2009
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphismsAnna Jakubowska, Jacek Gronwald, Janusz Menkiszak, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI TrialGregor Habl, Matthias Uhl, Sonja Katayama, et al.
Pageof 13